Gnostormon

Gnostormon is an oral vitamin D supplement containing the active ingredient colecalciferol. It is marketed in the European Union as an over‑the‑counter product for general use. The formulation provides a source of vitamin D to support calcium metabolism and bone health. While the specific strength and dosage form are not disclosed, the product follows EU regulatory standards for safety and quality and efficacy through.

Gnostormon is indicated for conditions where vitamin D levels are insufficient or where calcium metabolism needs support.

- Correction of documented vitamin D deficiency confirmed by serum 25‑hydroxyvitamin D testing. - Supplementation in individuals with low calcium intake to improve calcium absorption and balance. - Help maintain normal bone mineral density and reduce risk of bone demineralization in adults. - Support skeletal health and reduce fracture risk in older adults with age‑related bone loss. - Used as an adjunct in the management of osteomalacia or rickets when prescribed by a healthcare professional.

The safety profile of colecalciferol, the active ingredient in Gnostormon, reflects the typical effects observed with vitamin D supplementation.

Common: - Mild gastrointestinal discomfort such as nausea or abdominal cramps. - Transient headache or dizziness, especially after initiating therapy. - Slight increase in serum calcium levels that usually remains within normal limits. - Dry mouth or mild metallic taste, which usually resolves without intervention.

Serious: - Hypercalcemia presenting with excessive thirst, frequent urination, or kidney stones. - Allergic reactions including rash, itching, or swelling of the face and throat. - Severe hypercalcemia leading to cardiac arrhythmias or confusion (rare). - Calcification of soft tissues such as blood vessels in cases of prolonged excess intake.

When using Gnostormon, certain precautions should be observed to ensure safe and effective supplementation.

- Assess baseline serum 25‑hydroxyvitamin D and calcium levels before starting therapy. - Adjust dose in individuals with renal impairment or a history of hypercalcemia. - Avoid use in patients with known hypersensitivity to colecalciferol or any excipients. - Monitor calcium status periodically during long‑term use, especially in the elderly. - Keep out of reach of children; accidental ingestion of high doses can cause toxicity. - Do not exceed the recommended daily allowance without medical supervision.

Colecalciferol may interact with certain medications, influencing either vitamin D metabolism or calcium balance.

Avoid: - Thiazide diuretics, which can increase calcium reabsorption and raise the risk of hypercalcemia. - Vitamin K antagonists (e.g., warfarin), where high vitamin D levels may enhance anticoagulant effects. - Lithium therapy, as vitamin D excess may affect lithium levels and renal function.

Use with caution: - Calcium supplements or antacids containing calcium, as combined use may lead to excessive calcium levels. - Corticosteroids, which can reduce vitamin D activation and may require dose adjustment. - Orlistat, which can impair the absorption of fat‑soluble vitamins including vitamin D. - Bisphosphonates, where concurrent high vitamin D may increase risk of hypercalcemia after infusion.